Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Fibrosis × Amino Acids × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neuroendocrine Tumors 2 Neuroblastoma 2 Meningioma 2 Medulloblastoma 2 Malnutrition 2 Lung Neoplasms 1 Liver Neoplasms 1 Liver Failure 1 Hyperphagia 1 Hyperinsulinism 1 Hematologic Neoplasms 1 Fibrosis 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

Blood Specimen Collection 8 Magnetic Resonance Spectroscopy 5 Liver Transplantation 4 Tenofovir 3 Specimen Handling 3 Pentoxifylline 3 High-Energy Shock Waves 3 Sorafenib 2 Simvastatin 2 Low-Level Light Therapy 2 Gemcitabine 2 tremelimumab 1 sonidegib 1 sofosbuvir-velpatasvir drug combination 1 ruxolitinib 1 peginterferon alfa-2a 1 navitoclax 1 maltodextrin 1 hepatitis B hyperimmune globulin 1 esmolol 1 epigallocatechin gallate 1 durvalumab 1 contrast agent BR1 1 bavituximab 1 atezolizumab 1 apixaban 1 alpha-Tocopherol 1 adefovir dipivoxil 1 Viusid 1 Vitamin E 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03908255 2022-01-28

BCAA in HCC

Louisiana State University Health Sciences Center in New Orleans

Phase 2 Withdrawn

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Failure, Malnutrition

Data powered by HemOnc (CC BY 4.0) Colophon ⚡